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P2X receptors are trimeric cation channels with widespread roles
in health and disease. The recent crystal structure of a P2X4
receptor provides a 3D view of their topology and architecture. A
key unresolved issue is how ions gain access to the pore, because
the structure reveals two different pathways within the extracel-
lular domain. One of these is the central pathway spanning the
entire length of the extracellular domain and covering a distance
of ≈70 Å. The second consists of three lateral portals, adjacent to
the membrane and connected to the transmembrane pore by short
tunnels. Here, we demonstrate the preferential use of the lateral
portals. Owing to their favorable diameters and equivalent spac-
ing, the lateral portals split the task of ion supply threefold and
minimize an ion’s diffusive path before it succumbs to transmem-
brane electrochemical gradients.
fenestration | fractional calcium current | ligand-gated ion channel |
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P2X receptors are a family of ligand-gated ion channels thatopen when bound to extracellular ATP, providing a regulated
path for depolarizing cation current across cell surface mem-
branes. In mammals, the resulting entry of Ca2+ and Na+ triggers
muscle contraction, release of neurotransmitters, hormones, and
inﬂammatory mediators, as well as activation of downstream sig-
naling cascades (1, 2). In combination with a ubiquitous distribu-
tion, the widespread actions of ATP suggest that P2X receptors
play essential roles in the body. Indeed, advances with mouse
genetics and pharmacology show that P2X receptors are involved
in a variety of important physiological responses and disease states
(3), making them attractive targets for drug discovery. A key goal
is to understand how P2X receptors work at a molecular level.
The P2X receptor family is made of seven gene products,
designated P2X1–P2X7, that can form homomeric and/or het-
eromeric assemblies (4). One family member, the PX4 receptor, is
particularly prevalent in the central nervous system (5). This re-
ceptor is involved in microglia–neuron interactions, and mount-
ing evidence suggests it plays a critical role in neuropathic pain,
a persistent and prevalent form of pain whose molecular and
cellular neurobiology is poorly understood and for which there is
no effective treatment (6).
Each P2X4 receptor is made of three parts: an extracellular
domain containing the ATP binding site and the extracellular
vestibule of the ion channel, a transmembrane pore containing the
channel gate and selectivity ﬁlter, and an intracellular vestibule in
contact with the cytoplasm (7). The possibility that the permeation
pathway extends outward from the extracellular vestibule was not
considered until recently, when the newly solved crystal structure
of a closed state of the zebraﬁsh P2X4.1 receptor (zfP2X4.1R)
revealed, but failed to discriminate between, two possible paths in
the extracellular domain for ion passage to the pore (8). The ﬁrst is
the central pathway that spans the entire length of the extracel-
lular domain (Fig. 1A). The central pathway is lined with negative
charge and appears well suited to regulate cationic current (8, 9).
The second pathway is cast from three lateral portals formed
at the interfaces of adjoining subunits just above the outer leaﬂet
of the membrane (Fig. 1B). The lateral portals are less charged
than the central pathway, and less obstructed. Dual pathways are
also observed in acid sensing channels (10), but in neither case is it
known which pathway is functionally used as a cation pore.
Early work showed that replacing Ile328 of the rat P2X2 re-
ceptor (rP2X2R) with cysteine results in a mutant receptor whose
ATP-gated currents are sensitive to water-soluble, thiol-reactive
reagents (11, 12), and a recent report used the P2X2R-I328C
mutant to conclude that the lateral portals form an access route to
the transmembrane pore (13). However, Ile328 sits at the top of the
second transmembrane domain of the rP2X2R and is accessible to
thiol-reactive reagents that may travel through either the central
pathway or the lateral portals and, thus, this mutant does not ﬁrmly
establish the primary route of ion ﬂow. In the present report, we
used whole-cell as well as single-channel recordings, and applied
cationic and anionic methanethiosulfonates (MTS) and Cd2+ in
the presence and absence of ATP, tomeasure effects on gating and
conduction of a wide range of cysteine-substituted mutants of the
human P2X4 receptor (hP2X4R). Taken together, our experi-
ments provide convincing evidence that the lateral portals form the
primary access route to the hP2X4R and show that some residues
in the lateral portals are subject to allosteric modulation.
Results
We used cysteine-scanning mutagenesis (14) and measurements of
fractional Ca2+ current (Pf%) (15, 16) to investigate the con-
tributions of the two pathways to ionic current of the hP2X4R. We
studied the hP2X4R because of its high sequence identity to the
zfP2X4.1 form (Fig. S1) and, because, unlike the zfP2X4.1R (17), it
readily expresses in HEK293 cells and gives reproducible responses
to repeated applications of micromolar concentrations of ATP
(EC50 = 4.4 ± 0.9 μM; n= 6; Fig. 2A). Using a homology model of
the hP2X4R closed state, we identiﬁed residues that line the central
pathway and the lateral portals in their narrowest regions and, thus,
might be expected to interact with ions in the two putative perme-
ationpathways.We thenmutated the residues to cysteines, expressed
the mutants in HEK293 cells, and measured the accessibility of the
engineered thiol side chains to water-solublemethanethiosulfonates
(MTS) by means of electrophysiology (SI Methods). In control
experiments, we found no effect of 1 mM [2-(trimethylammonium)
ethyl]MTS+ (MTSET+) on the ATP-gated (100 μM) current of the
wild-type (wt) hP2X4R (Fig. 2 B and C).
To demonstrate feasibility, we used the published reports of
accessibility of cysteine-substituted rP2X2Rs (11, 12, 18, 19) to
suggest a residue in the transmembrane pore of hP2X4R (Ser341,
equivalent to rP2X2R-T336C) that should be accessible to
MTSET+ (Fig. S2A). As expected, we found that 1 mMMTSET+
irreversible reduced (99 ± 1%, n= 4) the agonist-gated current of
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the hP2X4R-S341C when coapplied with ATP (Fig. S2 B and E),
and that the rate of modiﬁcation (Kon = 4,387 ± 1,472 M
−1·s−1)
was comparable to that measured when MTSET+ and ATP are
coapplied to cysteine-substituted rP2X2R (18). Because the large
(6 × 6 × 10 Å) MTSET+ must ﬁrst traverse either the central
pathway or the lateral portals to reach S341C, this experiment serves
as a positive control to demonstrate that the relevant permeation
pathway is fully permeable to the thiol-modifying reagent.
Upper Vestibule. We examined the central pathway by placing
cysteines at sites in the upper vestibule where the diameter of the
channel is narrow (Fig. 2D). The ﬁrst site represents the out-
ermost entrance to the central pathway; it is obstructed in the
closed state model of hP2X4R, in part because the side chain of
Leu303 caps the opening. The entrance must open for current
to ﬂow, and we hypothesized that modiﬁcation by MTSET+ of
L303C would plug the open channel and reduce ATP-gated
current if the central pathway formed a conducting pore. How-
ever, we saw no effect of coapplying ATP and MTSET+ on
L303C currents (Fig. 2D), and no effect of MTSET+ on the
neighboring D302C and A304C residues (<5% change; n = 5).
We then moved inward, and placed cysteines near the top
(A297C; pore diameter ≈ 10 Å) and bottom (P92C and N93C;
pore diameter ≈ 5 Å; Fig. S3) of the upper vestibule, and again
saw no effect (<5% change; n = 5) of MTSET+ (for examples,
see Fig. 2D). The bulkier (≈8 × 16 × 16 Å) Texas Red-2-sulfo-
namidoethyl MTS (MTSTR) was also without effect at all of the
aforementioned residues, despite the fact that it irreversibly
blocks the current of the S341C transmembrane mutant (Fig. S2
C and E).
Next, we probed the narrow constriction (≈2.3 Å) between the
upper and central vestibules of the zfP2X4.1R formed in part by
three residues (Gln97, Glu98, Asp99), including Glu98 that coor-
dinates Gd3+ just above the entrance to the central vestibule (8).
We placed cysteines at the equivalent sites of the hP2X 4R (Gln94,
Glu95, Glu96; Fig. S3) and failed to measure an effect of MTSET+
(Fig. 2D and E) or MTSTR. Although it is possible that MTSET+
and MTSTR modify residues in the constriction without changing
current amplitude (14), the comparative dimensions of the MTS
head groups and the diameter of the pathway (8) render this highly
unlikely. Another possibility is that residues in the constriction are
inaccessible to MTSET+ and MTSTR, either because the central
pathway does not form a part of the ion channel pore, or because
large MTS reagents are impermeable. Although the latter option
seems unlikely because of the demonstrated accessibility of the
downstream S341C mutant, we nevertheless tested this possibility
by using Cd2+, a small metal element that binds to thiol side chains
exposed to water, as a permeable probe (19). We expected to
measure a change in the amplitude of theATP-gated current if the
coordinated ion occludes the channel or preferentially locks it in
the open or closed state, but we found that Cd2+ (20 μM) failed to
modify (<5% change; n= 6–7) the ATP-evoked currents of any of
these three hP2X4R mutants. When considered in concert with
the A93C/A297C/L303C experiments, our results argue against
the suggestion that the central pathway forms a major conduit for
ion conduction in the hP2X4R (8, 9).
Lateral Portals. We then tested the alternative hypothesis that
cations enter the transmembrane pore through the lateral portals.
We started by studying two acidic residues in the lateral portals
of the hP2X4R, Glu56 and Asp58 (Fig. 3A), that are common to
most (P2X2-P2X7) but not all (P2X1) human P2X receptors, and
that are thought to concentrate cations in the extracellular ves-
tibule of the zfP2X4.1R pore (8). Fig. 3 shows the effect of
coapplying MTSET+ and ATP. The results were qualitatively
similar in both mutants: MTSET+ caused irreversible reductions
in the amplitudes of the ATP-gated currents. In cells expressing
the E56C mutant, MTSET+ reduced current by 58 ± 4% (n= 9),
with an apparent modiﬁcation rate (Kon) of 7,057 ± 421 M
−1·s−1
(Fig. 3B). By comparison, MTSET+ caused a slower (Kon = 3,545
± 577 M−1·s−1) but more complete block (95 ± 1%, n = 8) of the
D58C mutant (Fig. 3C). The faster block of E56C may reﬂect
the fact that the substituted cysteine resides on the outer surface
of the portal where it is more accessible to MTSET+ than D58C
(Fig. S3).
Although Glu56 and Asp58 are positioned in the lateral portals/
extracellular vestibule, they also lie at the lowest point of the cen-
tral pathway. Therefore, it remained possible that the MTSET+-
sensitive currents move through the central pathway before react-
ing with the engineered thiolates. We addressed this possibility.
First, we measured MTSET+ reactivity in the absence of ATP.
The central pathway contains several narrowconstrictions thatmust
open to allow MTSET+ to access Glu56 and Asp58 (8). In contrast,
there is no barrier to current ﬂow in the portals that would prevent
modiﬁcation of the closed states of E56C and D58C mutants. We
established baseline responses to ATP (100 μM), and then applied
MTSET+ for 2–60 s in the absence of ATP. In all cases, MTSET+
caused signiﬁcant and persistent inhibitions of currents elicited by
subsequent applications ofATP (Fig. 3D andE). In some cases, the
ATP-gated currents showed a partial recovery in theﬁrst 3min after
washout of MTSET+. A similar effect is reported for MTSET+
inhibition of cysteine-substituted rat P2X4Rs, which is thought to
reﬂect recycling of unmodiﬁed receptors to the plasma membrane
(20) (see also ref. 7). However, in no case did the amplitude of the
ATP currents return to their control values, and a signiﬁcant in-
hibition remained even after a 15-min wash (Fig. 3 D–F). Further,
the persistent inhibition of ATP-gated current by MTSET+ was
immediately and fully reversed by the reducing agent, DTT (1 mM;
60 s) (Fig. 3 D–F). The same protocol had no effect on the wt
hP2X4R (Fig. 2C), or on mutant receptors containing cysteine
substitutions in the narrowest constriction of the central pathway
(Fig. 2E), suggesting that the majority of the plasmalemmal
E56C and D58C receptors were covalently modiﬁed by MTSET+.
Second, we measured the ability of an anionic MTS reagent to
modify E56C and D58C. The profoundly acidic surface of the
central vestibule of the zfP2X4.1R provides a long-range negative
electrostatic environment that favors the passage of cations over
anions (8, 13). The hP2X4R shows a modest Cl− permeability (21),
and we ﬁnd that the anionic thiol-reactive drug, (2-sulfonatoethyl)
MTS− (MTSES−), causes a fast (8,348 ± 867 M-1·s−1) and near
complete block of the S341C mutant (Fig. S2 D and E), as pre-
viously shown for the homologous residue (Thr336) of the rP2X2R
(11). LikeMTSET+,MTSES−must pass through either the central
pathway or the lateral portals before reaching S341C. Therefore,
Fig. 1. Alternative ion access routes to the pore of the hP2X4R. Illustrations
of the hP2X4R viewed parallel to the membrane plane. The cytoplasmic N-
and C-termini are missing because these domains are absent in the crystal
structure of the truncated zfP2X4.1 (8). The dotted lines show the limits of
the membrane. (A) A sagittal section (4 Å) of the central pathway shows the
pore-lining inner surface (gray mesh grid), highlighting the vestibules and
constrictions deﬁned by Kawate et al. (8). The orange spheres are spaced in
1-Å steps along the long axis of the pore and suggest a likely path for cations
to the cytoplasm if they entered through the central pathway (calculated by
using PoreWalker 1.0). (B) A space-ﬁlling model of the lateral portals, ex-
tracellular vestibule, and transmembrane pore (orange) as calculated by
using CAVER. Each portal (P1 to P3) has a wide (8 Å) and direct opening to
the extracellular vestibule of the transmembrane pore.
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we coapplied MTSES− (1 mM) and ATP (100 μM) to measure
accessibility and found that it modiﬁed both E56C and D58C
mutant receptors. MTSES− caused a small (34%) but signiﬁcant
(P = 0.0003) potentiation of current through hP2X4R-E56C and
a near complete block ofATP-gated current through hP2X4-D58C
(Fig. S4 A–C). In cysteine substituted accessibility experiments,
potentiation and block are both equally insightful and interpreted
to indicate side chain accessibility (14). Surprisingly, the apparent
modiﬁcation rate at position D58C was faster for MTSES− (Kon =
10,681± 1,123M-1·s−1, n=7) than forMTSET+ (≈3,500M−1·s−1).
We do not know why the anionic drug reacts quicker. Nonetheless,
the fast reaction rate suggests that MTSES− has an unimpeded
route of access to the thiol side chain of D58C, a situation that
favors the short and less charged environment of the lateral portals
over the longer and highly electronegative central pathway.
Finally, we measured the effect of MTSET+ and MTSES− on
T57C because it sits between the two acidic amino acids of the
lateral portals. Coapplication of MTSET+ caused a moderate
(27 ± 5%; n = 5) but signiﬁcant (P = 0.0004) inhibition of the
ATP-gated current of hP2X4R-T57C (Fig. S4D). In contrast,
MTSES−hadnoaffect.However, an initial applicationofMTSES−
prevented the inhibition of ATP-gated current by a subsequent
application of MTSET+ (Fig. S4E), showing that the anionic re-
agent modiﬁes the cysteine at position Tyr57.
Studies of Single Channel Current. The block of the ATP-gated
currents of hP2X4R-E56C and hP2X4-D58C by MTSET+ reﬂects
either a change in conductance or a change in gating (14). Al-
though both effects signal accessibility, a change in conductance is
the more direct demonstration that the modiﬁed side-chain lines
the permeation pathway (14, 22, 23). To measure a change in
conductance, we recorded ATP-gated single channel currents
from the membrane patches of HEK293 cells voltage-clamped at
−120 mV. The hP2X4R shows a fast and progressive loss of single
channel activity in excised patches that severely limits before and
after comparisons of drug effects (24). Rundown also occurs in
cell-attached patches, but at a slower rate that allows repeated
measurements of single channel current amplitude (Fig. S5A; ref.
24). Thus, we used the cell-attached mode to compare channel
amplitudes from populations of cells bathed in a physiological salt
solution with or without 1 mM MTSET+ before seal formation
(SI Methods).
We recorded bursts of single-channel current from wt (Fig.
S5B) and mutant hP2X4Rs (Fig. 4A) in the presence of ATP
(0.3–1 μM) that were never seen in the absence of agonist or in
untransfected cells. We found no difference in the conductances
of the wt hP2X4R and the E56C single channel currents that
measured 17.8 ± 0.8 pS (n = 7) and 16.2 ± 0.4 pS (n = 23), re-
spectively. In contrast, the conductance of the D58C mutant
(21.7 ± 0.6, n = 26) was signiﬁcantly larger than that of the other
two (P < 0.01), providing the ﬁrst clue that D58C lines the per-
meation pathway. We then compared the average current
amplitudes of the two cysteine-substituted receptors expressed in
HEK293 cells bathed for 3 min in 1 mM MTSET+ and saw sig-
niﬁcant (P < 0.0001) reductions (≈15% for E56C and ≈40% for
D58C) in the size of the single channel currents (Fig. 4B). The
fact that cysteine modiﬁcation decreases conductance provides
robust support for the model that E56C and D58C line the per-
meation pathway and, thus, validates the hypothesis that the lat-
eral portals are a primary entrance to the transmembrane pore.
The ATP-gated whole-cell current of the hP2X4R-E56C is
potentiated by coapplication of MTSES− (Fig. S4A). To de-
termine whether this potentiation reﬂects a change in conduction
or gating, we measured single channel current after anionic thi-
Fig. 2. MTSET+ has no effect on wt hP2X4R
and upper vestibule mutants. (A) Concen-
tration–response curve for the hP2X4R
generated by using perforated-patch elec-
trophysiology (SI Methods). In each cell, 30
μM ATP was applied ﬁrst, and then the effect
of subsequent doses were normalized to the
current caused by 30 μM ATP (I/I30μM, y axis).
(B) Sequential overlaid traces of ATP-gated
current, separated by 180s, are shown before
(black) and during (red) an application of
MTSET+. MTSET+ (1 mM; red bar) has no ef-
fect on membrane current of the wt hP2X4R
when coapplied with ATP (100 μM; black
bar). (C) MTSET+ (1 mM) has no effect on the
wt hP2X4R when applied in the absence of
ATP. C Upper shows the ATP-gated currents
caused by repeated applications (each 1-s
application is separated by 180s) before and
after a 60 s application of 1 mM MTSET+
(pink shaded rectangle). A subsequent ap-
plication of DTT (1 mM, 60 s; blue shaded
rectangle) also had no effect on the ATP-
gated currents. C Lower shows the averaged
data of individual measurements from ﬁve
or more cells. Peak amplitudes of ATP-gated
currents were normalized to the peak cur-
rent of the ATP-gated current that immedi-
ately preceded the application of MTSET+
(trial-1). (D) Coapplied MTSET
+ has no effect
on cysteine-substituted mutants of the cen-
tral pathway. The illustration shows one
subunit of the trimeric hP2X4R. The positions
of six of the nine substituted cysteines in the
central pathway are shown as spheres, and
the traces at Right show the lack of effect of
MTSET+ (red bars) on currents evoked by ATP
(black bars). (E) MTSET+ (1 mM) and DTT (1
mM) have no effect on mutants of the narrow constriction of the central pathway when applied in the absence of ATP. Each data point is the average of
individual determinations from seven or more cells measured using perforated-patch electrophysiology.
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olation and found a signiﬁcant (P < 0.0001) increase (≈24%) in
the size of the single channel current compared with control
(Fig. 4 A and B). The observation that MTSET+ and MTSES−
have opposite effects suggests a role for electrostatics in the
effect of thiolation on ATP-gated current at this position in the
lateral portals.
No Effect of Removing the Fixed Negative Charge of Glu56, Asp58, and
Glu95 on Ca2+ Current. In light of the apparent role of electrostatics
described above, we next tested the hypothesis put forth by Kawate
et al. that theﬁxednegative chargeofGlu56 andAsp58 creates a long-
range electrostatic potential that concentrates cations and repels
anions near the entrance to the transmembrane pore (8). Ca2+
carries twice the chargeofNa+and ismore sensitive to local changes
in electrostatic ﬁelds. Thus, we measured the fraction of the total
ATP-gated current carried by Ca2+, called the Pf%, by using patch
clamp photometry as described (21, 25). We constructed single
(E56Q, D58N) and double (E56Q/D58N) hP2X4R mutants with
reduced charge and found that the Pf% was unchanged (Fig. S6).
We therefore conclude that neither Glu56 nor Asp58 make a signiﬁ-
cant contribution to cation or anion selection in the hP2X4R, de-
spite the fact that they lie in the permeation pathway. This result is
consistent with the fact that the negative charges at these positions
are not absolutely conserved among cationic P2X receptors. In a
similar vein, we measured no effect of removing the carboxyl side
chain of Glu95 of the central pathway on the Pf% of the hP2X4R-
E95C mutant (Fig. S6D and E), despite the fact that this site forms
a cation-binding site in the zfP2X4.1R (8).
Our ﬁnding that removing the ﬁxed negative charge of Glu56
has no effect on Pf% is interesting in light of the opposite effects
of MTSET+ and MTSES− on the single channel conductance of
the E56C mutant (Fig. 4). Glu56 is on the outer rim of the lateral
portal where the negative charge of the native carboxylate may be
poorly positioned to alter current (Fig. S3). In contrast, the ad-
dition of the bulky (≈6 Å) anionic headgroup of MTSES− to the
cysteine mutant may place ﬁxed negative charge closer to the path
of ion ﬂow and, thus, increase single channel current by attracting
cations to the lateral portals.
Central Vestibule.We then extended our cysteine scan to determine
the accessibility of four sites (Ser59, Val61, Ser62, Asn97) in the
central vestibule to a rangeofMTS reagents (Fig. S3).Our rationale
for doing this experiment was as follows: The central vestibule sits
just above the lateral portals, and althoughmost cations that exit the
Fig. 3. MTSET+ modiﬁes residues of the lateral por-
tals. (A) Illustrations of hP2X4R showing the position
of Glu56 (blue spheres) and Asp58 (red spheres) in the
lateral portals. (B) MTSET+ (1 mM; red bars) inhibited
current through hP2X4R-E56C when coapplied with
ATP (100 μM; black bars). (C) MTSET+ (1 mM) caused
a near complete inhibition of current through
hP2X4R-D58C when coapplied with ATP (100 μM). (D
and E) MTSET+ (1 mM for 60 s; pink shade rectangles)
also inhibited current when applied in the absence of
ATP. The inhibitions by MTSET+ were reversed by 1
mM DTT (blue shaded rectangles). (F) Averaged data
for experiments like those of D and E. Each data point
is the average of individual measurements from 11 to
16 cells obtained by using perforated-patch electro-
physiology.
Fig. 4. Thiolation alters in single channel current. (A) Representative single-
channel currents of unmodiﬁed E56C and D58C receptors are shown at two
different time scales (Left). Center shows the reduction of current through
E56C and D58C in cells bathed in 1 mMMTSET+ before patch formation. Right
shows the increase in current amplitude in a cell expressing the E56C mutant
and exposed to 1 mM MTSES−. The dashed red lines indicate the average
single-channel current amplitude of the relevant unmodiﬁed mutant recep-
tors. (B) The histogram presents the average of all of the data shown in Fig.
S5C. Asterisks denote signiﬁcant differences (P < 0.01) in current amplitudes
for the E56C and D58C mutants measured before and after thiolation.
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portals probably move passively down the transmembrane electro-
chemical gradient and into the cell, some may be attracted to the
strong electronegative pull of acidic amino acids in the central
vestibule (8, 9). In keeping with this hypothesis, we found that
MTSET+ signiﬁcantly potentiated theATP-gated currents of S59C,
S62C, and N97C mutants (Fig. S7). In contrast, MTSES− potenti-
ated the current of the receptors carrying the S59C mutation that
sits just above the lateral portals, but neither altered ATP-gated
current nor masked the effects of MTSET+ on S62C and N97C.
Neither MTSET+ nor MTSES− affected V61C. Thus, our results
support the hypothesis of Kawate et al. that the negative electro-
static environment of the central vestibule attracts cations and
repels cations (8). The head groups of MTSET+ and MTSES− are
approximately the same size (14), which suggests that the lack of
effect of MTSES− on S62C and N97C cannot be explained by bulk
exclusion. Rather, the data imply that the strong electronegative
environment of the central cavity impedes the ﬂow of anions
through themiddle third of the central pathway, despite the fact that
MTSES− readily modiﬁes downstream engineered cysteines in the
lateral portals (E56C, D58C) and transmembrane pore (S341C).
Effect of Ivermectin on Thiolation. Ivermectin (IVM) increases
single channel conductance and lengthens mean open time of
P2X4 receptors (7, 24, 26), at least in part through intercalation
with the transmembrane helices (27). To determine whether the
lateral portals lie in the allosteric pathway, we assessed the effects
of MTSET+ on the E56C and D58C mutants before and after 5-
min preincubations in 1–10 μM IVM (Fig. 5A). IVM changed the
effect of MTSET+ in two ways. First, the rates of reaction were
signiﬁcantly slower (Kon values after 10 μM IVMwere 1,780 ± 387
(n = 5) and 1,084 ± 200 (n = 8) for E56C and D58C, re-
spectively). Second, the inhibitions by MTSET+ were signiﬁcantly
smaller (Fig. 5B). These ﬁndings are supported by experiments
using the smaller Cd2+ as modiﬁer. We found that Cd2+ caused
a pronounced potentiation and inhibition of the ATP-gated cur-
rents of the E56C and D58C mutants, respectively, and that both
effects of Cd2+ were absent after incubation with IVM (Fig. 5 C–
E). We interpret the data with MTSET+ and Cd2+ to indicate
that IVM changed the shape of the portals through an allosteric
mechanism and, hence, the nature of the thiol modiﬁcation.
Discussion
Themainﬁndings of this study are that cations gain access to the ion
selective transmembrane pore via the lateral portals of P2X recep-
tors and that ion ﬂow through the portals is allosterically regulated.
The coordination of Gd3+ by Glu98 in the closed state structure
of the zfP2X4.1 was interpreted to suggest that the central
pathway might be a conduit for cation ﬂow (8). However, Glu98 is
not well conserved, and the surmountable nature of the block of
ATP-evoked currents by Gd3+ is inconsistent with pore block (8).
In relation to these facts, we found no evidence using substituted
cysteine mutagenesis or measurements of Pf% to suggest that the
central pathway is a conductive entrance to the pore.
However, our experiments provide strong evidence to suggest
that ions preferentially ﬂow to the pore via the symmetrically
placed lateral portals. Thus, coapplication of ATP and either
MTSET+ or MTSES− causes a near complete block of current
through the D58C mutant (Fig. 3C and Fig. S4B), showing that, at
least under these circumstances, all or almost all of the current that
enters the transmembrane pore passes ﬁrst through the lateral
portals. Further, MTSES− is excluded from parts of the central
pathway (Fig. S7) but is still capable of modifying S341C in the
transmembrane pore (Fig. S2D). In some ways the use of lateral
portals makes intuitive sense, because some ions that traverse the
central pathway might exit the pore through the three wide lateral
portals rather than proceed into the single transmembrane pore.
Further, the portals are short and unobstructed. The use of lateral
portals therefore appears to be an efﬁcient mechanism to facilitate
unimpeded ion ﬂow as it splits the task threefold between portals,
exploits the favorable electrostatic environment near the plasma
membrane outer leaﬂet, and reduces the diffusive path for cations.
Our ﬁnding that MTSET+ reduces both whole-cell and single-
channel current of the D58C mutant suggests this modiﬁcation
exerts a “bulk” effect in the portals that impedes the ﬂow of ions.
Cationic thiolation of D58C results in a signiﬁcant (40%) re-
duction in single channel current that is smaller than the block of
the whole-cell current (95%). The inability of thiolation to com-
pletely block single channel current by adding bulk to portal-lining
residues is not surprising for two reasons. First, the lateral portals
are unusually wide by comparison with the pore-lining trans-
membrane domains that are typical targets of thiolation studies of
ion permeation (8). Second, each portal presents a single D58C
side chain formodiﬁcation, unlike transmembrane pores that show
multiple axes of symmetry. Thus, the addition of the headgroup of
MTSET+ to a single cysteinyl side chain in a wide lateral portal
may not fully plug the opening. If so, then the almost complete
reduction in whole-cell current by MTSET+ must reﬂect changes
in both conduction and gating. A change in gating after thiolation
Fig. 5. IVM reduces MTSET+ and Cd2+ modiﬁcation of the lateral portals. (A)
The ﬁgure shows the ATP-gated current before (black traces) and during
(red traces) coapplication of 1 mM MTSET+ in two cells preincubated in 10
μM IVM for 5 min, and then maintained in IVM for the duration of the ex-
periment (≈10 min). The traces are normalized to their peak current
amplitudes. MTSET+ still blocks the ATP-gated current in cells expressing
E56C and D58C and soaked in IVM, but the effect is smaller and slower. (B)
Summary data for the block of MTSET+ in the absence (black) and presence
(red striped) of IVM. **, signiﬁcantly different from wt hP2X4; *, signiﬁ-
cantly different from the wt and the −IVM condition (P < 0.001). (C) Nor-
malized traces show control (black; 100 μM ATP alone) and test traces
(green; 100 μM ATP followed by 20 μM Cd2+ applied for the duration in-
dicated by the green bar) for wt hP2X4 and the indicated cysteine mutants.
Arrows point to profound potentiation and block of E56C and D58C mutants
by Cd2+. (D) As in C, but for cells that had been bathed in 1 μM IVM for 2–5
min before the start of the recording and then also for the duration of the
recording. (E) Summary data for experiments such as those in C and D for wt
hP2X4R and E56C and D58C mutants. Relative to the wt hP2X4R, Cd2+ appli-
cations to E56C and D568C mutants signiﬁcantly potentiated and reduced
ATP-evoked responses; further these effects were abolished in the presence of
IVM. The data are shown as average ± SEM (n = 5–16). **, signiﬁcantly dif-
ferent from wt hP2X4R; *, signiﬁcantly different from the −IVM condition.
13804 | www.pnas.org/cgi/doi/10.1073/pnas.1017550108 Samways et al.
is more often the rule than the exception (14). Nevertheless, our
ﬁnding that MTSET+ (and MTSES−) change the amplitudes of
the single channel currents of E56C and D58C provides unusually
strong support for the hypothesis that the lateral portals form
a primary entrance to the transmembrane ion conduction pathway.
A dual effect on conduction and gating may also explain the
smaller effect ofMTSET+ on homologous residues of the rP2X2R.
The effect of MTSET+ on the ATP-gated current of rP2X2R-
D57C and rP2X2R-E59C is smaller (28) than the effect on the
homologous residues (E56C, D58C) of hP2X4R, which could be
explained if some of the effect of thiolation results from a change in
gating, as discussed above. In fact, the gating behavior of rP2X2R
and hP2X4R differ in sensitivity to agonists, antagonists, and al-
losteric modulators like pH and IVM (29). Perhaps then we should
not be surprised that the effect of thiolation also differs between
P2X receptors. Nevertheless, the route of access is the main con-
sideration, and our data clearly show that MTS reagents alter
ATP-gated current of the hP2X4R by entering the lateral portals.
Some of the accessible residues (Ser59, Ser62, Asn97) that are
potentiated by thiolation map to a region between the proposed
ATP binding site and the outer end of TM1, composed of “con-
necting rods” that link ATP binding to movement of the trans-
membrane domains (30). Residues in this part of the protein are
thought to be involved in gating (30, 31). Our results suggest that
the connecting rods form a surface of the portals and vestibules
that is accessible to application of water-soluble thiol-reactive
reagents that travel through the lateral portals even when the
transmembrane channel gate is closed. Further, our data with
IVM, a known allosteric regulator of P2X4 receptors, provides
good evidence that altered gating can affect the nature of acces-
sibility in the portals. This observation, along with the connecting
rods model, implies that ion ﬂow through the lateral portals and
receptor gating may be linked. These ﬁndings raise the possibility
that ion access to the hP2X4R portals could be targeted with
designer drugs, which may ﬁnd applications in therapy of P2X4-
associated disorders. In future work it will be useful to explore this
possibility when a 3D structure of the open channel bound to
ATP becomes available.
In conclusion, our experiments show a pattern of hits in cys-
teine scanning accessibility experiments (Fig. S8) that strongly
suggest that ions access the pore of a P2X receptor by making
preferential use of three radially symmetric and unobstructed
lateral portals. Although we found no evidence to support cur-
rent ﬂow through the central pathway, it is still a possibility that
this route is used under conditions that differ from those used in
our experiments, for example, when the concentration of extra-
cellular divalents is lowered to promote pore dilation (1). Finally,
our ﬁndings are directly relevant to trimeric acid sensing chan-
nels (9, 10) and to structural and mechanistic studies of other
membrane proteins containing portals (32, 33), which may also
be regulated and used by the transported species.
Methods
Methods are fully described in SI Methods. In short, whole-cell and single-
channel currents were recorded from cultured HEK293 cells that transiently
expressed either wt or cysteine-substituted hP2X4Rs. Broken-patch voltage-
clamp was used to record whole-cell current when one or two applications of
ATP were sufﬁcient to compete the goals the experiment. To prevent run-
down with repeated drug applications, the perforated-patch voltage clamp
was used to record whole-cell current when more than two applications were
required. Thiol modiﬁcation was determined from changes in ATP-gated (100
μM) current measured before, during, and after applications of MTS (1 mM) or
Cd2+ (20 μM). Single-channel current was recorded from cell-attached patches
of cells whose membrane potential was zeroed by a bath solution containing
154 mM K+. The transmembrane potential was set to −120 mV by applying
current to the recording electrode. Recording electrodes were ﬁlled with
a solution containing 140 mM NaF and 0.1–1.0 μM ATP. Pf%was measured as
described (20, 24).
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SI Methods
Homology Modeling. Human and zebraﬁsh P2X4 sequences have
57.5% identity and 74.9% similarity, and we therefore used the
crystal structures of the zfP2X.1R (1) as templates to build
a hP2X4R model. First, the highest resolution structure of
zfP2X4.1R (PDB ID code 3H9V), which contained only one
monomer, was used to create a 3D model of a hP2X4R monomer
by using the homology modeling server SWISSMODEL (2). In
a second step, the lower resolution structure of the full zfP2X4.1R
trimer (PDB ID code 3I5D) was used to direct the symmetry of
three hP2X4Rmonomers, which constituted the complete model.
Finally, the hP2X4R model was minimized by using the GRO-
MOS force-ﬁeld implemented in the program DEEP VIEW (3).
The root mean square deviation between single chains of the
hP2X4 model and zfP2X4.1 structure is 0.11 Å (alignment of
329 atoms), demonstrating a good ﬁt of the model to the struc-
ture. Because zfP2X4.1R was solved as a truncated receptor
missing both the N- and C- intracellular domains, these domains
are absent in our homology model of the hP2X4R. At present,
data do not support a role for these domains in forming the ion
channel pore.
The central ion pathway was calculated by using PORE
WALKER 1.0 (4). CAVER 2.0 v0.003 (5) was used to map the
alternative ion pathway through the lateral portals. The starting
point for calculation was deﬁned as the resulting coordinates of
Ser341 from each subunit. The results are displayed by using Py-
Mol 1.3 (Schrödinger, LLC).
Cell Culture and Molecular Biology. HEK293 cells were maintained
in exponential growth in DMEM supplemented with 10% heat-
inactivatedFBS, 2mMglutamine, 50 units/mLpenicillinG, and 50
μg/mL streptomycin (all reagents from Invitrogen) and incubated
at 37 °C in a humidiﬁed atmosphere with 5%CO2. Upon reaching
70–80% conﬂuency in 75-cm2 tissue culture ﬂasks, the cells were
enzymatically dissociated, and transfected with a P2X plasmid
and a ﬂuorescent reporter gene by using Lipofectamine LTX
(Invitrogen). The cells were replated in 35-mm culture dishes and
left to grow for 48 h before use in experiments. Mutagenesis was
accomplished by using the QuikChange Lightning Site-Directed
Mutagenesis kit (Agilent Technologies) and veriﬁed by auto-
mated DNA sequencing (Retrogen).
Whole-Cell Electrophysiology. We used standard broken-patch
whole-cell recording technique when one or twoATP applications
were needed to complete an experiment (see, for example, Fig. 2B
and D), and we used the perforated-patch method when >2 drug
applications were needed (see, for example, Fig. 2 C and E). The
broken-patch method is quicker and more efﬁcient that the per-
forated-patch method, but complicated by a progressive loss of
peak current amplitude in response to repeated applications of
ATP. In contrast, we saw reproducible responses to ATP when
using the perforated-patch method, as reported for the rat P2X1
receptor (6). On the morning of an experiment, transfected cells
on 35-mm plates were dissociated by using a Trypsin/EDTA so-
lution (Invitrogen), and then replated at low density for 2 h before
experiments began. Then, the cells were again dispersed by me-
chanical agitation of the culture media, and an aliquot of dis-
persed cells was transferred to a recording chamber mounted an
inverted ﬂuorescence microscope. Current was recorded from
single cells by using Axon 200b ampliﬁers (Mechanical Devices),
ITC-16 D/A boards (Heka Instruments), and AxoGraphX Soft-
ware (AxoGraph). Current was low pass ﬁltered at 1 kHz, sam-
pled at a rate of 10 kHz, and stored on magnetic drives for off-line
analyses. Drugs were applied by using the Perfusion Fast-Step
SF-77 System (Warner Instruments). For a more complete de-
scription of our perforated-patch methods, see Migita et al. (7)
and Li et al. (8). For a complete description of the broken-patch
method and our protocol to measure the effects of Cd2+ on P2X
receptors, see Kracun et al. (9).
Single-Channel Electrophysiology. Cells were maintained and dis-
persed as described above. Single-channel current was recorded
from cell-attached patches from dispersed cells by using ﬁre-
polished 7052 glass electrodes (Garner Glass Company) with
open tip resistances of 5–12 MΩ. These electrodes were coated at
their tips with HIPEC R6101 semiconductor protective coating
(Dow Corning) and ﬁlled with a solution of the following com-
position: 0.0003–0.001 mM ATP, 140 mM NaF, 5 mM NaCl, 10
mM Hepes, 1 mM CaCl2 at pH 7.3 with NaOH. We used a high
K+ solution of the following composition to set the trans-
membrane potential of the whole cell close to 0 mV: 154 mM
KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM glucose, 10 mM Hepes
at pH 7.4 with KOH. After formation of the gigaseal (>10 GΩ),
current was low-pass ﬁltered at 5 kHz, digitized direct to the
computer hard drive at a sampling rate of 50 kHz, and sub-
sequently analyzed off-line by using IGOR Pro (Wavemetrics).
The currents shown in Fig. 4 and Fig. S5 were furthered ﬁltered
at 2 kHz using the low-pass software ﬁlter of AxoGraphX for
display only. Single-channel current amplitude was estimated
from the best Gaussian ﬁt to an all-points amplitude histogram
of a leak-subtracted trace of a single burst of ATP-gated channel
activity, using IGOR Pro.
Statistical Analyses. All data are presented as the mean ± SEM.
Drug treatments were analyzed by comparing data obtained
before, during, and after drug treatment by using the Student t
test function. Groups of data were analyzed by one-way ANOVA
with signiﬁcance determined from the Tukey’s protected multi-
ple comparison test using Instat (GraphPad Software). A P ≤
0.01 was considered signiﬁcant.
Patch Clamp Photometry. Pf% was determined by using the dye-
overload method of Neher (10) and Dani (11) as described in
detail in published papers from our laboratory (12, 13). ATP-
gated whole-cell current was recorded from adherent HEK293
cells by using a recording pipette containing 140 mM CsCl, 10
mM tetraethylammonium, 3 mM CsOH, 10 mM Hepes, and 2
mM K5-fura-2. These cells were perfused with an extracellular
buffer containing 140 mM NaCl, 2 mM CaCl2, 1 mM MgCl2, 3
mM NaOH (pH 7.4), 10 mM glucose, and 10 mM Hepes. Fura-2
ﬂuorescence was measured with a Model 714 Photomultiplier
Detection System (Photon Technology International). Pf% was
determined from the following equation:
Pf% ¼ ΔF380=Fmax
QT
× 100;
where ΔF380 is the change in fura-2 ﬂuorescence caused by Ca
2+
entry, QT is the leak-subtracted integrated current recorded us-
ing patch clamp electrophysiology, and Fmax is a proportionality
constant determined as described (12).
Effects of Thiol-Reactive Reagents. Thiol modiﬁcation was de-
termined from changes in ATP-gated current measured before,
during, and after applications ofMTSorCd2+. In all cases, we used
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a saturating concentration of ATP (100 μM) to fully activate the
receptor, and at least 3 min passed between applications to min-
imize rundown. For modiﬁcation in the absence of ATP (i.e.,
closed state modiﬁcation), we measured the membrane current
elicited by short (1 s) applications of ATP (100 μM) applied before
and after a 2- to 60-s application of 1 mMMTS alone by using the
perforated-patch technique of whole-cell voltage clamp. Percent
change was determined from the average of the peak current
amplitudes of ﬁve applications of ATP administered before and
after MTS. For modiﬁcation during channel gating (open state
modiﬁcation), we initiated an agonist response by applying 100
μM ATP, and then switched to a solution containing ATP and
either MTS (1 mM for 3 s) or Cd2+ (20 μM for 15 s). In this case,
we recorded current by using the whole-cell voltage-clamp tech-
nique because it is more expeditious than the perforated-patch
method. (In control experiments, we found no difference between
methods in the effect of thiol-reactive reagents on agonist-gated
current when coapplied with ATP). Then, the percent change
was determined by dividing the agonist-gated current amplitude
measured just before application of MTS or Cd2+, by the agonist-
gated current amplitude measured at the end of the rapid (usually
<1 s) exponential fade in current caused by the thiol modiﬁer.
We assume that the reaction ofMTS with the thiol side chain of
cysteine is irreversible. If so, then the apparent rate of modiﬁ-
cation rate (Kon) is equal to:
Kon ¼ 1
τon × ½MTS ;
where τon is the time constant of modiﬁcation measured from the
single exponential ﬁt of the immediate change in agonist-gated
current that occurs upon introduction of an MTS reagent.
Pharmacology. In each cell, ATP-gated current was normalized by
dividing its peak amplitude by the average of the peak amplitudes
of two or more previous applications of 30 μMATP, as described
(8). Concentration–response curves for individual cells were then
ﬁt with the Hill equation by using the Levenberg–Marquardt
algorithm implemented in IGOR Pro (Wavemetrics):
Y ¼ Ymax
1þ ðEC50=XÞnH
;
where Y is the current amplitude, and X is the concentration of
ATP. The ﬁt was used to estimate the maximum response (Ymax),
the concentration of ATP needed to generate the half-maximal
response (EC50), and the Hill slope (nH). Current amplitudes
after MTSET+ were normalized to control responses to 30 μM
ATP measured before thiol modiﬁcation.
1. Kawate T, Michel JC, BirdsongWT, Gouaux E (2009) Crystal structure of the ATP-gated
P2X(4) ion channel in the closed state. Nature 460:592–598.
2. Schwede T, Kopp J, Guex N, Peitsch MC (2003) SWISS-MODEL: An automated protein
homology-modeling server. Nucleic Acids Res 31:3381–3385.
3. Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: An environment
for comparative protein modeling. Electrophoresis 18:2714–2723.
4. Pellegrini-Calace M, Maiwald T, Thornton JM (2009) PoreWalker: A novel tool for the
identiﬁcation and characterization of channels in transmembrane proteins from their
three-dimensional structure. PLOS Comput Biol 5:e1000440.
5. Petrek M, et al. (2006) CAVER: A new tool to explore routes from protein clefts,
pockets and cavities. BMC Bioinformatics 7:316.
6. Lewis CJ, Evans RJ (2000) Lack of run-down of smooth muscle P2X receptor currents
recorded with the amphotericin permeabilized patch technique, physiological and
pharmacological characterization of the properties of mesenteric artery P2X receptor
ion channels. Br J Pharmacol 131:1659–1666.
7. Migita K, Haines WR, Voigt MM, Egan TM (2001) Polar residues of the second
transmembrane domain inﬂuence cation permeability of the ATP-gated P2X(2)
receptor. J Biol Chem 276:30934–30941.
8. Li Z, Migita K, Samways DS, Voigt MM, Egan TM (2004) Gain and loss of channel
function by alanine substitutions in the transmembrane segments of the rat ATP-
gated P2X2 receptor. J Neurosci 24:7378–7386.
9. Kracun S, Chaptal V, Abramson J, Khakh BS (2010) Gated access to the pore of a P2X
receptor: Structural implications for closed-open transitions. J Biol Chem 285:10110–
10121.
10. Schneggenburger R, Zhou Z, Konnerth A, Neher E (1993) Fractional contribution of
calciumto the cation current throughglutamate receptor channels.Neuron11:133–143.
11. Vernino S, RogersM, Radcliffe KA, Dani JA (1994) Quantitativemeasurement of calcium
ﬂux through muscle and neuronal nicotinic acetylcholine receptors. J Neurosci 14:
5514–5524.
12. Egan TM, Khakh BS (2004) Contribution of calcium ions to P2X channel responses.
J Neurosci 24:3413–3420.
13. Samways DS, Egan TM (2007) Acidic amino acids impart enhanced Ca2+ permeability
and ﬂux in two members of the ATP-gated P2X receptor family. J Gen Physiol 129:
245–256.
14. Priel A, Silberberg SD (2004) Mechanism of ivermectin facilitation of human P2X4
receptor channels. J Gen Physiol 123:281–293.
Fig. S1. Sequence alignment of hP2X4R and zfP2X4R4.1 with the truncated 315D-A and 3H9V-A structures of Kawate et al (1).
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Fig. S2. The effect of three MTS reagents on the transmembrane hP2X4R-S341C mutant. (A) The transmembrane position of Ser341 in shown in a single
subunit of trimeric hP2X4R. ATP current through hP2X4R-S341C was irreversibly inhibited by MTSET+ (B), MTSTR (C), and MTSES− (D). In each case, the traces
are normalized to peak currents. (E) Average data of ﬁve or more cells. The black bars represent the average response of wt hP2X4R to each MTS reagent.
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Fig. S3. Surface representation of hP2X4R showing residues in the lateral portals, extracellular vestibule, and central vestibule. (A) All three subunits of the
trimeric protein at the level of the lateral portals. (B) The subunit at the back of the protein is removed to clearly show a portal entrance formed by adjoining
subunits. (C) The front subunit is removed to show positions of residues tested in this study.
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Fig. S4. The effects of MTSES− on E56C, T57C, and D58C. (A) MTSES− (1 mM) caused a slow (Kon = 847 ± 109, n = 9) potentiation of current through E56C. Black
trace is control, and blue trace is a recording showing the effect of coapplication of MTSES−. (B) MTSES− (1 mM) caused a near complete block of current
through D58C mutants. (C) Averaged data for MTSES−. The asterisks indicate signiﬁcant differences from the wt hP2X4R (P < 0.001). MTSES− had no signiﬁcant
effect on the wt hP2X4R (n = 5). (D) MTSET+ blocks the ATP-gated current of the T57C mutant. Black trace is control, and red trace is a recording showing the
effect of coapplication of MTSET+. (E) Shown are two traces, separated by a 10-min wash. First, MTSES− was coapplied with ATP (blue trace). This was then
followed by coapplication of MTSET+ and ATP. Previous exposure to MTSES− blocked the inhibitory effect of MTSET+ (see D) on the ATP-gated current.
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Fig. S5. (A) The traces show the single channel activity of a cell-attached patch from a HEK293 cell expressing hP2X4R-D58C. The transmembrane potential
was −120 mV, and the recording electrode contained a NaF solution and 1 μM ATP. See SI Methods for a complete description of the protocol. The recording
began ≈20 s after formation of the gigaseal. The patch contained at least four receptors whose activity gradually decreased over time. The three lower panels
show 5 s segments of the upper trace on an expanded time scale. (B) Single-channel current of the wt hP2X4R shown at two different time scales. We found
that the hP2X4R opened in bursts of channel activity as described (14). (C) Scatter plot of the single-channel current amplitudes of all data used to construct the
bar graph of Fig. 4B. ATP-gated channels were identiﬁed as bursts of openings that were unlikely any seen in the absence of ATP. The data of each column
shows a normal distribution.
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Fig. S6. Pf% is unchanged in hP2X4R mutants. Representative current and ﬂuorescence recordings for portal mutants hP2X4R-E56C (A), hP2X4R-D58C (B), and
hP2X4RE56C/D58C (C) expressed in HEK293 cells. ATP (30 μM) was applied for 2 s. In each case, Upper shows the ATP-gated current, and Lower shows the
charge carried by Ca2+ (i.e., QCa, blue traces, determined from ﬂuorescence; see SI Methods) relative (shaded area) to the total ATP-gated charge (i.e., QT, black
traces). We also measured the Pf% of the hP2X4R-95C mutant (D). We did this experiment because the homologous residue (Glu98) is suggested to form
a cation-binding site in the zfP2X4.1R. We saw no effect on Pf% of removing the carboxylate side chain. (E) Averaged data. In all cases, the Pf% values were
not signiﬁcantly different from that of the wild-type receptor (P > 0.05).
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Fig. S7. The effects of MTSET+ and MTSES− on S59C, S62C, and N97C in the central cavity measured by using broken-patch whole cell electrophysiology. (A)
Both MTSET+ (Left) and MTSES− (Right) potentiate the current of the S59C mutant generated by using a saturating dose (100 μM) of ATP. (B and C) In HEK293
cells expressing either the hP2X4R-S62C (A) or hP2X4R-N97C (B) mutant, application of MTSES− (1 mM) in the presence of ATP cause no change in current
amplitude (blue traces). However, unlike the situation seen using the T57C mutant (Fig. S4E), a prior application of MTSES− does not prevent a potentiation
caused by a subsequent coapplication of ATP and MTSET+ (red traces). These data suggest that S62C and N97C, which are positioned in the upper part of the
central vestibule (Fig. S3), are inaccessible to the anionic modifying reagent.
Fig. S8. Illustration of hP2X4R showing the locations of cysteine substitutions that render the mutants sensitive to modiﬁcation by MTSET+ alone (red) or both
MTSET+ and MTSES− (green). Positions carrying cysteine mutations that conferred no sensitivity are shown in black.
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